The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years.
about
Elimination of endogenous toxin, creatinine from blood plasma depends on albumin conformation: site specific uremic toxicity & impaired drug bindingScreening for decreased glomerular filtration rate and associated risk factors in a cohort of HIV-infected patients in a middle-income countryAortic calcification and femoral bone density are independently associated with left ventricular mass in patients with chronic kidney diseaseAssociation between moderate renal insufficiency and cardiovascular events in a general population: Tehran lipid and glucose study.Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review.Salt-induced changes in cardiac phosphoproteome in a rat model of chronic renal failure.Chronic kidney disease and end-stage renal disease-a review produced to contribute to the report 'the status of health in the European union: towards a healthier Europe'.Cross-talk between endothelin-1 and mineral metabolism in hemodialysis patients: a cross-sectional study.Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to comChronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort studyArterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort studyCorrelation between serum uric Acid and renal function in patients with stable coronary artery disease and type 2 diabetes.Low ankle-brachial index is associated with early-stage chronic kidney disease in type 2 diabetic patients independent of albuminuria.Estimated glomerular filtration rate in a population with normal to mildly reduced renal function as predictor of cardiovascular disease.What is new in uremic toxicity?Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad.Screening for albuminuria identifies individuals at increased renal riskEstimated GFR associates with cardiovascular risk factors independently of measured GFR.Dyslipidemia associated with chronic kidney diseaseDarbepoetin alpha reduces oxidative stress and chronic inflammation in atherosclerotic lesions of apo E deficient mice in experimental renal failure.Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney DiseaseSystolic Heart Function, Kidney Filtration and the Number of Coronary Atherosclerotic Plaques in Lean and Overweight PatientsSymmetric dimethylarginine as a proinflammatory agent in chronic kidney diseaseGlobal Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-AnalysisLong term prognosis of acute coronary syndrome with chronic renal dysfunction treated in different therapy units at department of cardiology: a retrospective cohort study.Major influence of renal function on hyperlipidemia after living donor liver transplantation.The simplified modification of diet in renal disease equation as a predictor of renal function after coronary artery bypass graft surgery.Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients.The predictive value of arterial stiffness on major adverse cardiovascular events in individuals with mildly impaired renal function.Kidney function and estimated vascular risk in patients with primary dyslipidemiaEstimating Negative Effect of Abdominal Obesity on Mildly Decreased Kidney Function Using a Novel Index of Body-Fat Distribution.Understanding the effects of chronic kidney disease on cardiovascular risk: are there lessons to be learnt from healthy kidney donors?Fenofibrate and the kidney: an overview.Ankle-brachial Index for the Prognosis of Cardiovascular Disease in Patients with Mild Renal Insufficiency.Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.Prevalence of chronic renal failure stage 3 or more in HIV-infected patients in Antwerp: an observational study.Markers of endothelial damage in patients with chronic kidney disease on hemodialysis.Chronic kidney disease prevalence in the general population: heterogeneity and concerns.Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and E supplementation.
P2860
Q28477294-91242291-7772-4B10-B513-178A47F1E388Q28541930-1D5FC518-F23C-40EF-84AC-3A51270B5E67Q28728330-2F7A3FE2-50B0-4D65-B91A-947C9E82B708Q31073301-5D6DF0F9-DBD2-42B9-8ACA-4800D58E2CF5Q33297377-4C3F2E2F-41E8-482D-B37A-787D23E724B0Q33778975-F2F1599E-F473-4020-AF39-32354E7AD7A9Q33816875-E6A66412-5F12-40D1-9A8F-3D2183802997Q33918306-ACA2AC9C-883D-4BEC-921E-042FE62C1863Q33960590-F8563FF2-E7CE-4B12-942E-939947C351CDQ34168772-9165BADF-5E26-4B8C-BF95-95D38BED2191Q34207275-73192AF9-70D8-4A7F-9916-5B8D172AF429Q34213027-9455F696-B78B-4EE6-AA31-8D7D1E3B1B9CQ34420483-C08BF0DD-F783-41A8-ACB8-DA8C061BCB51Q34574712-760ED243-83A0-4CEC-9902-47D9336F40A4Q34589157-F11FD2D0-63FB-4773-A26F-E8A50E7315A1Q34595173-E0D0A921-3171-4277-B79D-D7B4CC6F7BD7Q34658059-B9A1DA24-BE0C-4F81-AB5A-B7A259D4AE4AQ34870809-385AF52F-892B-4A44-9D7E-BB3CE5BCD8A1Q35020237-C40B9E25-B19A-41D1-9F69-64BFD64E80EBQ35106161-75AEEC05-3342-487C-BBEF-5E6D72AA8D45Q35620125-7FEBCCD9-7997-49ED-BF39-1E73BD99C2E3Q35914820-7C293684-3E2E-4232-BFD2-46915BE0E2BEQ35976000-D0225CCA-039B-473B-A36B-54FDDCEA5863Q35985806-ADE37B93-F51B-4BEC-812C-8EB333D0BE2DQ36068812-91F185F6-99ED-4FF0-9571-2C0630E6B4E1Q36411818-C79CFD1C-3CFB-42C0-89C7-89E235389F4AQ36492663-9E6764BA-6084-4239-A99D-6C9CBB9FE85FQ37041336-FF850F08-F75C-4FD7-A439-87817A2C24E6Q37100557-8A849737-3D40-48E8-9738-DE5E8C7DE249Q37229608-50A11237-A021-48BC-95DF-133C6B6F7EE8Q37245464-890F7F46-C107-4B23-8203-AABD9C0C898EQ37677727-D7A6221B-3676-472A-BD41-C7D84B754119Q37877133-BAC423C8-DFAC-48AA-8E23-D82B9B915DD2Q38088377-1D5F0030-71C0-4096-9C10-A5EBAE96E4FBQ38646310-3F1273F3-1F48-4747-BC9B-405D64B16700Q38853235-854CDBFD-8EE8-40D1-AD37-D0B9BC8A54AEQ38951176-81AEC1D5-14E3-4328-B451-4F2192E5FDB7Q39026344-EEC41178-7015-4827-9165-8F765E14BCFFQ40891501-519E68FD-DF3F-4414-992B-3D31260468CDQ43734669-D7E81828-6494-4B16-80BD-618B78CA5E80
P2860
The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
The glomerular filtration rate ...... lar mortality during 10 years.
@en
The glomerular filtration rate ...... lar mortality during 10 years.
@nl
type
label
The glomerular filtration rate ...... lar mortality during 10 years.
@en
The glomerular filtration rate ...... lar mortality during 10 years.
@nl
prefLabel
The glomerular filtration rate ...... lar mortality during 10 years.
@en
The glomerular filtration rate ...... lar mortality during 10 years.
@nl
P2093
P356
P1476
The glomerular filtration rate ...... lar mortality during 10 years.
@en
P2093
Dirk De Bacquer
Francis Verbeke
Joris Delanghe
Norbert Lameire
P304
P356
10.1093/EURHEARTJ/EHL455
P577
2007-01-12T00:00:00Z